Carminita Lara Frost

Prof. Carminita Lara Frost

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2021 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
AHAmy de la Harpe
Amy de la Harpe
Natasha BeukesNatasha Beukes
Natasha Beukes
CFCarminita Lara Frost
Carminita Lara Frost

14 October 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RSRecardia Schoeman
Recardia Schoeman
Natasha BeukesNatasha Beukes
Natasha Beukes
CFCarminita Lara Frost
Carminita Lara Frost
This study evaluated the synergistic anti-cancer potential of cannabinoid combinations across the MDA-MB-231 and MCF-7 human breast cancer cell lines. Cannabinoids were combined and their synergistic interactions were evaluated using median effect analysis. The most promising cannabinoid combination (C6) consisted of tetrahydrocannabinol, cannabigerol (CBG), cannabinol (CBN), and cannabidiol (CBD), and displayed favorable dose reduction indices and limited cytotoxicity against the non-cancerous breast cell line, MCF-10A. C6 exerted its effects in the MCF-7 cell line by inducing cell cycle arrest in the G2 phase, followed by the induction of apoptosis. Morphological observations indicated the induction of cytoplasmic vacuolation, with further investigation suggesting that the vacuole membrane was derived from the endoplasmic reticulum. In addition, lipid accumulation, increased lysosome size, and significant increases in the endoplasmic reticulum chaperone protein glucose-regulated protein 78 (GRP78) expression were also observed. The selectivity and ability of cannabinoids to halt cancer cell proliferation via pathways resembling apoptosis, autophagy, and paraptosis shows promise for cannabinoid use in standardized breast cancer treatment.


1 April 2015 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
IGIsaac Z. Gundhla
Isaac Z. Gundhla
RWRyan S. Walmsley
Ryan S. Walmsley
VUVital Ugirinema
Vital Ugirinema
NMNandipha O. Mnonopi
Nandipha O. Mnonopi
EHEric Cyriel Hosten
Eric Cyriel Hosten
ZTZenixole R. Tshentu
Zenixole R. Tshentu

9 May 2024 in Cell Proliferation
Verified
Journal Article
Open access
AHA. de la Harpe
A. de la Harpe
NBN. Beukes
N. Beukes
CFCarminita Lara Frost
Carminita Lara Frost
Studies have shown that natural products can induce paraptosis in tumour cell lines. Paraptosis is characterized by cytoplasmic vacuolation arising from the endoplasmic reticulum (ER) and mitochondria. The mechanism of paraptosis is unclear; however, dysregulation of Ca2+ homeostasis is believed to affect paraptosis induction. This study investigated the mechanism of cell death induced by a phytocannabinoid ratio in the MCF7 breast cancer cell line. The crystal violet assay was used to detect changes in viability and morphology changes were investigated using light and transmission electron microscopy. Various inhibitors, fluorescent staining with high‐content screening, and Western blot analysis were used to investigate different cell death mechanisms. The phytocannabinoid ratio induced significant cell death and cytoplasmic vacuolation in MCF7 cells; however, no apoptosis, necrosis, autophagy, or ferroptosis was detected. Vacuolation induced by phytocannabinoid treatment was inhibited by cycloheximide, suggesting paraptosis induction. The mechanism of paraptosis induction was investigated, and it was found that treatment (1) induced ER dilation and mitochondrial swelling, (2) induced significant ER stress and mitochondrial Ca2+ overload and dysfunction, which appeared to be mediated by the voltage‐dependent anion channel, and (3) significantly impaired all mitochondrial metabolic pathways. The data demonstrated that paraptosis induced by the cannabinoid ratio was mediated by Ca2+ flux from the ER to the mitochondria. These findings highlight a novel mechanism of cannabinoid‐induced cell death and emphasize the anti‐cancer potential of cannabinoid ratios, which exhibited enhanced effects compared to individual cannabinoids.

1 November 2014 in Journal of Pharmacy and Pharmacology
Verified
Journal Article
Closed access
PDF file
Natasha BeukesNatasha Beukes
Natasha Beukes
RLRuby-Ann Levendal
Ruby-Ann Levendal
CFCarminita Lara Frost
Carminita Lara Frost